Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Poonawalla Fincorp Ltd, Kajaria Ceramics Ltd, Aadhar Housing Finance Ltd, SBI Life Insurance Company Ltd are among the other stocks to see a surge in volumes on BSE today, 28 July 2025.
Laurus Labs Ltd registered volume of 5.58 lakh shares by 10:46 IST on BSE, a 6.88 fold spurt over two-week average daily volume of 81093 shares. The stock rose 5.78% to Rs.886.45. Volumes stood at 1.44 lakh shares in the last session.
Poonawalla Fincorp Ltd saw volume of 3.01 lakh shares by 10:46 IST on BSE, a 5.05 fold spurt over two-week average daily volume of 59535 shares. The stock increased 6.24% to Rs.439.30. Volumes stood at 1.15 lakh shares in the last session.
Kajaria Ceramics Ltd witnessed volume of 12.48 lakh shares by 10:46 IST on BSE, a 4.66 times surge over two-week average daily volume of 2.68 lakh shares. The stock increased 1.05% to Rs.1,179.70. Volumes stood at 4.16 lakh shares in the last session.
Aadhar Housing Finance Ltd registered volume of 4.11 lakh shares by 10:46 IST on BSE, a 4.19 fold spurt over two-week average daily volume of 98011 shares. The stock rose 4.53% to Rs.519.40. Volumes stood at 56797 shares in the last session.
SBI Life Insurance Company Ltd recorded volume of 72077 shares by 10:46 IST on BSE, a 3.28 times surge over two-week average daily volume of 21965 shares. The stock gained 0.67% to Rs.1,845.15. Volumes stood at 64706 shares in the last session.
Profit before tax (PBT) stood at Rs 224 crore for Q1 June 2025, reflecting a 1,144% increase over Q1 June 2024.
EBITDA was Rs 389 crore in Q1 June 2025, up 127% compared to Q1 June 2024. EBITDA margin rose to 24.8%, up from 14.3% in Q1 June 2024.
In Q1 FY26, Laurus Labs’ Contract Development and Manufacturing Operations (CDMO) revenue more than doubled year-on-year to Rs 522 crore, driven by a 130% increase in small molecules revenue, although the bio-segment saw a 33% decline. Revenue from the Generics division rose 12% to Rs 1,048 crore, with APIs dipping 4% but finished dosages (FDF) surging 50%. Additionally, ARV revenues advanced 17% to Rs 647 crore during the period under review.
Dr. Satyanarayana Chava, founder & chief executive officer commented: 'We made healthy progress to start the year with increasing contributions from CDMO business and continued advancement of pipeline projects, supported by Generic FDF. We are moving ahead with strong focus on commercial execution realizing the full potential from promising pipeline opportunities, business development and rapidly enhancing scale and technology capabilities. We also commenced construction of various facilities across CDMO, Generics and FDF. Once complete, these facilities will fortify our ongoing commitment of being a high-quality development and manufacturing partner at scale including advanced therapies. We remain confident in our strategic direction and commitment as the source of sustainable value creation now and well into the future.'
V V Ravi Kumar, executive director & chief financial officer commented: 'We delivered a solid performance in Q1, in line with expectations. We are pleased to see sustained growth momentum fueled by increasing uptake in CDMO deliveries and healthy business fundamentals. The EBITDA margins improved substantially to 24.8%, supported by continuing operating leverage. Gross margins stood strong at 59.4% due to favorable CDMO mix and ongoing process improvement initiatives. We will continue to invest fully behind high value business opportunities to drive near and long-term growth and returns for our shareholders.'
Meanwhile, the Government of Andhra Pradesh has allotted 531.77 acres of land in IP Rambilli Phase-II, Anakapalli District, to the company for the establishment of Laurus Pharma Zone (LPZ), where it plans to set up manufacturing units for pharmaceutical products. Laurus Labs has earmarked an investment of Rs 5,630 crore for this project, which is expected to generate employment for 6,350 people in three phases over eight years. This land allotment marks a significant milestone, securing a crucial component for the company’s future expansion plans.
Laurus Labs is a research-driven pharmaceutical and biotechnology company. It develops and manufactures select Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) across anti-retroviral, oncology, cardiovascular, and gastro therapeutics. It offers end-to-end CDMO services, supporting innovators from early-stage development to commercial production.
Laurus Labs Ltd, ACME Solar Holdings Ltd, Kotak Mahindra Bank Ltd, Aadhar Housing Finance Ltd are among the other stocks to see a surge in volumes on NSE today, 28 July 2025.
Poonawalla Fincorp Ltd clocked volume of 111.77 lakh shares by 14:14 IST on NSE, a 8.55 times surge over two-week average daily volume of 13.07 lakh shares. The stock gained 3.42% to Rs.427.45. Volumes stood at 30.03 lakh shares in the last session.
Laurus Labs Ltd notched up volume of 148.43 lakh shares by 14:14 IST on NSE, a 8.09 fold spurt over two-week average daily volume of 18.34 lakh shares. The stock rose 6.78% to Rs.894.55. Volumes stood at 52.68 lakh shares in the last session.
ACME Solar Holdings Ltd saw volume of 114.76 lakh shares by 14:14 IST on NSE, a 7.61 fold spurt over two-week average daily volume of 15.08 lakh shares. The stock increased 7.43% to Rs.290.55. Volumes stood at 14.35 lakh shares in the last session.
Kotak Mahindra Bank Ltd witnessed volume of 112.49 lakh shares by 14:14 IST on NSE, a 5.06 times surge over two-week average daily volume of 22.22 lakh shares. The stock dropped 7.55% to Rs.1,964.10. Volumes stood at 17.45 lakh shares in the last session.
Aadhar Housing Finance Ltd clocked volume of 64.43 lakh shares by 14:14 IST on NSE, a 3.75 times surge over two-week average daily volume of 17.17 lakh shares. The stock gained 3.81% to Rs.515.30. Volumes stood at 6.28 lakh shares in the last session.
Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 893.5, up 6.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 24744.75. The Sensex is at 81052.89, down 0.5%. Laurus Labs Ltd has risen around 23.27% in last one month.
Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 3.26% in last one month and is currently quoting at 22662.7, up 0.42% on the day. The volume in the stock stood at 132.02 lakh shares today, compared to the daily average of 25.38 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 894.85, up 6.89% on the day. Laurus Labs Ltd is up 98.12% in last one year as compared to a 0.37% drop in NIFTY and a 4.99% drop in the Nifty Pharma index.
The PE of the stock is 133.02 based on TTM earnings ending March 25.